DirectorMoves Eli Kalif

Teva Pharmaceutical (NYSE: TEVA) $9.26b Eli Kalif named CFO xo Flex Ltd SVP Finance

$$$$ Base $650,000; Bonus 100% of base; Sign-on equity award RSUs value at $250,000

https://www.tevapharm.com/about/corporate_governance/board_of_directors/

https://www.linkedin.com/in/eli-kalif-18264848/